Virtu Financial’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Buy |
+12,555
| New | +$22K | ﹤0.01% | 1245 |
|
|
2025
Q1 | – | Sell |
-63,276
| Closed | -$468K | – | 1674 |
|
|
2024
Q4 | $468K | Buy |
+63,276
| New | +$468K | 0.02% | 527 |
|
|
2024
Q3 | – | Sell |
-94,099
| Closed | -$755K | – | 1614 |
|
|
2024
Q2 | $755K | Buy |
+94,099
| New | +$755K | 0.05% | 353 |
|
|
2023
Q3 | – | Sell |
-21,851
| Closed | -$154K | – | 1577 |
|
|
2023
Q2 | $154K | Buy |
+21,851
| New | +$154K | 0.01% | 898 |
|
|
2021
Q2 | – | Sell |
-42,480
| Closed | -$1.35M | – | 1772 |
|
|
2021
Q1 | $1.35M | Buy |
42,480
+35,981
| +554% | +$1.14M | 0.1% | 183 |
|
|
2020
Q4 | $302K | Sell |
6,499
-12,212
| -65% | -$567K | 0.03% | 639 |
|
|
2020
Q3 | $616K | Sell |
18,711
-1,120
| -6% | -$36.9K | 0.11% | 233 |
|
|
2020
Q2 | $544K | Buy |
+19,831
| New | +$544K | 0.06% | 346 |
|
|
2019
Q4 | – | Sell |
-11,814
| Closed | -$215K | – | 1627 |
|
|
2019
Q3 | $215K | Buy |
+11,814
| New | +$215K | 0.02% | 933 |
|
|
2019
Q2 | – | Sell |
-10,385
| Closed | -$99K | – | 1624 |
|
|
2019
Q1 | $99K | Buy |
+10,385
| New | +$99K | 0.01% | 1119 |
|
|
2018
Q4 | – | Sell |
-60,812
| Closed | -$684K | – | 1749 |
|
|
2018
Q3 | $684K | Buy |
+60,812
| New | +$684K | 0.04% | 466 |
|
|
2018
Q1 | – | Sell |
-22,861
| Closed | -$183K | – | 2259 |
|
|
2017
Q4 | $183K | Buy |
+22,861
| New | +$183K | 0.01% | 1720 |
|